APO Research
Talk to an analyst

APO RESEARCH · REPORT

Phosphate Buffered Saline (PBS) Tablet

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Phosphate Buffered Saline (PBS) Tablet Market Outlook and Growth Opportunities 2026

4 July 2026190 pages

Choose your research edition.

Industry ResearchPhosphate Buffered Saline (PBS) Tablet Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Phosphate Buffered Saline (PBS) Tablet Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Phosphate Buffered Saline (PBS) Tablet Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Phosphate Buffered Saline (PBS) Tablet Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Phosphate Buffered Saline (PBS) Tablet Market Analysis and Forecast 2026-2032171 pages · $4,950 USD

Market perspective

The global Phosphate Buffered Saline (PBS) Tablet market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Phosphate Buffered Saline (PBS) Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Phosphate Buffered Saline (PBS) Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Phosphate Buffered Saline (PBS) Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Phosphate Buffered Saline (PBS) Tablet market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Phosphate Buffered Saline (PBS) Tablet market include Merck, Valiant, Tocris Bioscience, Thermo Fisher, Takara Bio, Spectrum Chemical, R-Biopharm AG, R&D Systems and Novus Biologicals, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Phosphate Buffered Saline (PBS) Tablet market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Phosphate Buffered Saline (PBS) Tablet and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Phosphate Buffered Saline (PBS) Tablet revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Phosphate Buffered Saline (PBS) Tablet market.

Phosphate Buffered Saline (PBS) Tablet Segment by Company

Merck

Valiant

Tocris Bioscience

Thermo Fisher

Takara Bio

Spectrum Chemical

R-Biopharm AG

R&D Systems

Novus Biologicals

MyBioSource

Medicago AB

Bio Basic

Phosphate Buffered Saline (PBS) Tablet Segment by Type

Soluble in 500ML Water

Soluble in 200ML Water

Soluble in 100ML Water

Others

Phosphate Buffered Saline (PBS) Tablet Segment by Application

University Laboratory

Business Research Institute

Others

Phosphate Buffered Saline (PBS) Tablet Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Phosphate Buffered Saline (PBS) Tablet status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Phosphate Buffered Saline (PBS) Tablet key companies, revenue, market share, and recent developments.

3. To split the Phosphate Buffered Saline (PBS) Tablet breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Phosphate Buffered Saline (PBS) Tablet market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Phosphate Buffered Saline (PBS) Tablet significant trends, drivers, influence factors in global and regions.

6. To analyze Phosphate Buffered Saline (PBS) Tablet competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Phosphate Buffered Saline (PBS) Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Phosphate Buffered Saline (PBS) Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Phosphate Buffered Saline (PBS) Tablet.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Phosphate Buffered Saline (PBS) Tablet industry.

Chapter 3: Detailed analysis of Phosphate Buffered Saline (PBS) Tablet company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Phosphate Buffered Saline (PBS) Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Phosphate Buffered Saline (PBS) Tablet in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Phosphate Buffered Saline (PBS) Tablet Industry Trends Table 2. Phosphate Buffered Saline (PBS) Tablet Industry Drivers Table 3. Phosphate Buffered Saline (PBS) Tablet Industry Opportunities and Challenges Table 4. Phosphate Buffered Saline (PBS) Tablet Industry Restraints Table 5. Global Phosphate Buffered Saline (PBS) Tablet Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Phosphate Buffered Saline (PBS) Tablet Revenue Share by Company (2021-2026) Table 7. Global Phosphate Buffered Saline (PBS) Tablet Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Phosphate Buffered Saline (PBS) Tablet Key Company Manufacturing Base & Headquarters Table 9. Global Phosphate Buffered Saline (PBS) Tablet Company, Product Type & Application Table 10. Global Phosphate Buffered Saline (PBS) Tablet Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Phosphate Buffered Saline (PBS) Tablet by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Soluble in 500ML Water Table 15. Significant Companies of Soluble in 200ML Water Table 16. Significant Companies of Soluble in 100ML Water Table 17. Significant Companies of Others Table 18. Global Phosphate Buffered Saline (PBS) Tablet Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Phosphate Buffered Saline (PBS) Tablet Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Phosphate Buffered Saline (PBS) Tablet Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type (2021-2026) Table 22. Global Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type (2027-2032) Table 23. Significant Companies of University Laboratory Table 24. Significant Companies of Business Research Institute Table 25. Significant Companies of Others Table 26. Global Phosphate Buffered Saline (PBS) Tablet Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Phosphate Buffered Saline (PBS) Tablet Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Phosphate Buffered Saline (PBS) Tablet Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application (2021-2026) Table 30. Global Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application (2027-2032) Table 31. Global Phosphate Buffered Saline (PBS) Tablet Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Phosphate Buffered Saline (PBS) Tablet Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Region (2021-2026) Table 34. Global Phosphate Buffered Saline (PBS) Tablet Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Region (2027-2032) Table 36. Global Phosphate Buffered Saline (PBS) Tablet Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Phosphate Buffered Saline (PBS) Tablet Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Phosphate Buffered Saline (PBS) Tablet Sales Value Market Share by Country (2021-2026) Table 39. Global Phosphate Buffered Saline (PBS) Tablet Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Phosphate Buffered Saline (PBS) Tablet Sales Value Market Share by Country (2027-2032) Table 41. Merck Company Information Table 42. Merck Business Overview Table 43. Merck Phosphate Buffered Saline (PBS) Tablet Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Merck Phosphate Buffered Saline (PBS) Tablet Product Portfolio Table 45. Merck Recent Development Table 46. Valiant Company Information Table 47. Valiant Business Overview Table 48. Valiant Phosphate Buffered Saline (PBS) Tablet Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Valiant Phosphate Buffered Saline (PBS) Tablet Product Portfolio Table 50. Valiant Recent Development Table 51. Tocris Bioscience Company Information Table 52. Tocris Bioscience Business Overview Table 53. Tocris Bioscience Phosphate Buffered Saline (PBS) Tablet Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Tocris Bioscience Phosphate Buffered Saline (PBS) Tablet Product Portfolio Table 55. Tocris Bioscience Recent Development Table 56. Thermo Fisher Company Information Table 57. Thermo Fisher Business Overview Table 58. Thermo Fisher Phosphate Buffered Saline (PBS) Tablet Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Thermo Fisher Phosphate Buffered Saline (PBS) Tablet Product Portfolio Table 60. Thermo Fisher Recent Development Table 61. Takara Bio Company Information Table 62. Takara Bio Business Overview Table 63. Takara Bio Phosphate Buffered Saline (PBS) Tablet Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Takara Bio Phosphate Buffered Saline (PBS) Tablet Product Portfolio Table 65. Takara Bio Recent Development Table 66. Spectrum Chemical Company Information Table 67. Spectrum Chemical Business Overview Table 68. Spectrum Chemical Phosphate Buffered Saline (PBS) Tablet Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Spectrum Chemical Phosphate Buffered Saline (PBS) Tablet Product Portfolio Table 70. Spectrum Chemical Recent Development Table 71. R-Biopharm AG Company Information Table 72. R-Biopharm AG Business Overview Table 73. R-Biopharm AG Phosphate Buffered Saline (PBS) Tablet Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. R-Biopharm AG Phosphate Buffered Saline (PBS) Tablet Product Portfolio Table 75. R-Biopharm AG Recent Development Table 76. R&D Systems Company Information Table 77. R&D Systems Business Overview Table 78. R&D Systems Phosphate Buffered Saline (PBS) Tablet Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. R&D Systems Phosphate Buffered Saline (PBS) Tablet Product Portfolio Table 80. R&D Systems Recent Development Table 81. Novus Biologicals Company Information Table 82. Novus Biologicals Business Overview Table 83. Novus Biologicals Phosphate Buffered Saline (PBS) Tablet Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Novus Biologicals Phosphate Buffered Saline (PBS) Tablet Product Portfolio Table 85. Novus Biologicals Recent Development Table 86. MyBioSource Company Information Table 87. MyBioSource Business Overview Table 88. MyBioSource Phosphate Buffered Saline (PBS) Tablet Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. MyBioSource Phosphate Buffered Saline (PBS) Tablet Product Portfolio Table 90. MyBioSource Recent Development Table 91. Medicago AB Company Information Table 92. Medicago AB Business Overview Table 93. Medicago AB Phosphate Buffered Saline (PBS) Tablet Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Medicago AB Phosphate Buffered Saline (PBS) Tablet Product Portfolio Table 95. Medicago AB Recent Development Table 96. Bio Basic Company Information Table 97. Bio Basic Business Overview Table 98. Bio Basic Phosphate Buffered Saline (PBS) Tablet Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Bio Basic Phosphate Buffered Saline (PBS) Tablet Product Portfolio Table 100. Bio Basic Recent Development Table 101. Research Programs/Design for This Report Table 102. Authors List of This Report Table 103. Secondary Sources Table 104. Primary Sources List of Figures Figure 1. Phosphate Buffered Saline (PBS) Tablet Product Image Figure 2. Global Phosphate Buffered Saline (PBS) Tablet Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Phosphate Buffered Saline (PBS) Tablet Market Size (2021-2032) & (US$ Million) Figure 4. Global Phosphate Buffered Saline (PBS) Tablet Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Soluble in 500ML Water Image Figure 8. Soluble in 200ML Water Image Figure 9. Soluble in 100ML Water Image Figure 10. Others Image Figure 11. Global Phosphate Buffered Saline (PBS) Tablet Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Phosphate Buffered Saline (PBS) Tablet Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type (2021-2032) Figure 14. University Laboratory Image Figure 15. Business Research Institute Image Figure 16. Others Image Figure 17. Global Phosphate Buffered Saline (PBS) Tablet Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Phosphate Buffered Saline (PBS) Tablet Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application (2021-2032) Figure 20. Global Phosphate Buffered Saline (PBS) Tablet Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Phosphate Buffered Saline (PBS) Tablet Sales Value (2021-2032) & (US$ Million) Figure 23. North America Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Phosphate Buffered Saline (PBS) Tablet Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Phosphate Buffered Saline (PBS) Tablet Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Phosphate Buffered Saline (PBS) Tablet Sales Value (2021-2032) & (US$ Million) Figure 29. South America Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Phosphate Buffered Saline (PBS) Tablet Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Soluble in 500ML Water
  • Soluble in 200ML Water
  • Soluble in 100ML Water
  • Others
Applications
  • University Laboratory
  • Business Research Institute
  • Others
Companies covered
  • Merck
  • Valiant
  • Tocris Bioscience
  • Thermo Fisher
  • Takara Bio
  • Spectrum Chemical
  • R-Biopharm AG
  • R&D Systems
  • Novus Biologicals
  • MyBioSource
  • Medicago AB
  • Bio Basic

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Phosphate Buffered Saline (PBS) Tablet Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Phosphate Buffered Saline (PBS) Tablet Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Phosphate Buffered Saline (PBS) Tablet Market Dynamics
  1. 2.1 Phosphate Buffered Saline (PBS) Tablet Industry Trends
  2. 2.2 Phosphate Buffered Saline (PBS) Tablet Industry Drivers
  3. 2.3 Phosphate Buffered Saline (PBS) Tablet Industry Opportunities and Challenges
  4. 2.4 Phosphate Buffered Saline (PBS) Tablet Industry Restraints
3 Phosphate Buffered Saline (PBS) Tablet Market by Company
  1. 3.1 Global Phosphate Buffered Saline (PBS) Tablet Company Revenue Ranking in 2025
  2. 3.2 Global Phosphate Buffered Saline (PBS) Tablet Revenue by Company (2021-2026)
  3. 3.3 Global Phosphate Buffered Saline (PBS) Tablet Company Ranking (2024-2026)
  4. 3.4 Global Phosphate Buffered Saline (PBS) Tablet Company Manufacturing Base and Headquarters
  5. 3.5 Global Phosphate Buffered Saline (PBS) Tablet Company Product Type and Application
  6. 3.6 Global Phosphate Buffered Saline (PBS) Tablet Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Phosphate Buffered Saline (PBS) Tablet Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Phosphate Buffered Saline (PBS) Tablet Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Phosphate Buffered Saline (PBS) Tablet Market by Type
  1. 4.1 Phosphate Buffered Saline (PBS) Tablet Type Introduction
  2. 4.1.1 Soluble in 500ML Water
  3. 4.1.2 Soluble in 200ML Water
  4. 4.1.3 Soluble in 100ML Water
  5. 4.1.4 Others
  6. 4.2 Global Phosphate Buffered Saline (PBS) Tablet Sales Value by Type
  7. 4.2.1 Global Phosphate Buffered Saline (PBS) Tablet Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Phosphate Buffered Saline (PBS) Tablet Sales Value by Type (2021-2032)
  9. 4.2.3 Global Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type (2021-2032)
5 Phosphate Buffered Saline (PBS) Tablet Market by Application
  1. 5.1 Phosphate Buffered Saline (PBS) Tablet Application Introduction
  2. 5.1.1 University Laboratory
  3. 5.1.2 Business Research Institute
  4. 5.1.3 Others
  5. 5.2 Global Phosphate Buffered Saline (PBS) Tablet Sales Value by Application
  6. 5.2.1 Global Phosphate Buffered Saline (PBS) Tablet Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Phosphate Buffered Saline (PBS) Tablet Sales Value by Application (2021-2032)
  8. 5.2.3 Global Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application (2021-2032)
6 Phosphate Buffered Saline (PBS) Tablet Regional Value Analysis
  1. 6.1 Global Phosphate Buffered Saline (PBS) Tablet Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Phosphate Buffered Saline (PBS) Tablet Sales Value by Region (2021-2032)
  3. 6.2.1 Global Phosphate Buffered Saline (PBS) Tablet Sales Value by Region: 2021-2026
  4. 6.2.2 Global Phosphate Buffered Saline (PBS) Tablet Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Phosphate Buffered Saline (PBS) Tablet Sales Value (2021-2032)
  7. 6.3.2 North America Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Phosphate Buffered Saline (PBS) Tablet Sales Value (2021-2032)
  10. 6.4.2 Europe Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Phosphate Buffered Saline (PBS) Tablet Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Phosphate Buffered Saline (PBS) Tablet Sales Value (2021-2032)
  16. 6.6.2 South America Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Phosphate Buffered Saline (PBS) Tablet Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Country, 2025 VS 2032
7 Phosphate Buffered Saline (PBS) Tablet Country-level Value Analysis
  1. 7.1 Global Phosphate Buffered Saline (PBS) Tablet Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Phosphate Buffered Saline (PBS) Tablet Sales Value by Country (2021-2032)
  3. 7.2.1 Global Phosphate Buffered Saline (PBS) Tablet Sales Value by Country (2021-2026)
  4. 7.2.2 Global Phosphate Buffered Saline (PBS) Tablet Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck
  2. 8.1.1 Merck Company Information
  3. 8.1.2 Merck Business Overview
  4. 8.1.3 Merck Phosphate Buffered Saline (PBS) Tablet Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Merck Phosphate Buffered Saline (PBS) Tablet Product Portfolio
  6. 8.1.5 Merck Recent Developments
  7. 8.2 Valiant
  8. 8.2.1 Valiant Company Information
  9. 8.2.2 Valiant Business Overview
  10. 8.2.3 Valiant Phosphate Buffered Saline (PBS) Tablet Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Valiant Phosphate Buffered Saline (PBS) Tablet Product Portfolio
  12. 8.2.5 Valiant Recent Developments
  13. 8.3 Tocris Bioscience
  14. 8.3.1 Tocris Bioscience Company Information
  15. 8.3.2 Tocris Bioscience Business Overview
  16. 8.3.3 Tocris Bioscience Phosphate Buffered Saline (PBS) Tablet Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Tocris Bioscience Phosphate Buffered Saline (PBS) Tablet Product Portfolio
  18. 8.3.5 Tocris Bioscience Recent Developments
  19. 8.4 Thermo Fisher
  20. 8.4.1 Thermo Fisher Company Information
  21. 8.4.2 Thermo Fisher Business Overview
  22. 8.4.3 Thermo Fisher Phosphate Buffered Saline (PBS) Tablet Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Thermo Fisher Phosphate Buffered Saline (PBS) Tablet Product Portfolio
  24. 8.4.5 Thermo Fisher Recent Developments
  25. 8.5 Takara Bio
  26. 8.5.1 Takara Bio Company Information
  27. 8.5.2 Takara Bio Business Overview
  28. 8.5.3 Takara Bio Phosphate Buffered Saline (PBS) Tablet Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Takara Bio Phosphate Buffered Saline (PBS) Tablet Product Portfolio
  30. 8.5.5 Takara Bio Recent Developments
  31. 8.6 Spectrum Chemical
  32. 8.6.1 Spectrum Chemical Company Information
  33. 8.6.2 Spectrum Chemical Business Overview
  34. 8.6.3 Spectrum Chemical Phosphate Buffered Saline (PBS) Tablet Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Spectrum Chemical Phosphate Buffered Saline (PBS) Tablet Product Portfolio
  36. 8.6.5 Spectrum Chemical Recent Developments
  37. 8.7 R-Biopharm AG
  38. 8.7.1 R-Biopharm AG Company Information
  39. 8.7.2 R-Biopharm AG Business Overview
  40. 8.7.3 R-Biopharm AG Phosphate Buffered Saline (PBS) Tablet Revenue and Gross Margin (2021-2026)
  41. 8.7.4 R-Biopharm AG Phosphate Buffered Saline (PBS) Tablet Product Portfolio
  42. 8.7.5 R-Biopharm AG Recent Developments
  43. 8.8 R&D Systems
  44. 8.8.1 R&D Systems Company Information
  45. 8.8.2 R&D Systems Business Overview
  46. 8.8.3 R&D Systems Phosphate Buffered Saline (PBS) Tablet Revenue and Gross Margin (2021-2026)
  47. 8.8.4 R&D Systems Phosphate Buffered Saline (PBS) Tablet Product Portfolio
  48. 8.8.5 R&D Systems Recent Developments
  49. 8.9 Novus Biologicals
  50. 8.9.1 Novus Biologicals Company Information
  51. 8.9.2 Novus Biologicals Business Overview
  52. 8.9.3 Novus Biologicals Phosphate Buffered Saline (PBS) Tablet Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Novus Biologicals Phosphate Buffered Saline (PBS) Tablet Product Portfolio
  54. 8.9.5 Novus Biologicals Recent Developments
  55. 8.10 MyBioSource
  56. 8.10.1 MyBioSource Company Information
  57. 8.10.2 MyBioSource Business Overview
  58. 8.10.3 MyBioSource Phosphate Buffered Saline (PBS) Tablet Revenue and Gross Margin (2021-2026)
  59. 8.10.4 MyBioSource Phosphate Buffered Saline (PBS) Tablet Product Portfolio
  60. 8.10.5 MyBioSource Recent Developments
  61. 8.11 Medicago AB
  62. 8.11.1 Medicago AB Company Information
  63. 8.11.2 Medicago AB Business Overview
  64. 8.11.3 Medicago AB Phosphate Buffered Saline (PBS) Tablet Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Medicago AB Phosphate Buffered Saline (PBS) Tablet Product Portfolio
  66. 8.11.5 Medicago AB Recent Developments
  67. 8.12 Bio Basic
  68. 8.12.1 Bio Basic Company Information
  69. 8.12.2 Bio Basic Business Overview
  70. 8.12.3 Bio Basic Phosphate Buffered Saline (PBS) Tablet Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Bio Basic Phosphate Buffered Saline (PBS) Tablet Product Portfolio
  72. 8.12.5 Bio Basic Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst